Showing 61 - 70 of 951
Persistent link: https://www.econbiz.de/10011718925
Persistent link: https://www.econbiz.de/10011568759
Persistent link: https://www.econbiz.de/10003960046
The trend towards giving consumers choice about their health plans has invited research on how good they actually are at making these decisions. The introduction of Medicare Part D is an important example. Initial plan choices in this market were generally far from optimal. In this paper, we...
Persistent link: https://www.econbiz.de/10012455915
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10012460495
Much has been said about the stylized fact that the economically successful are not only wealthier but also healthier than the less affluent. There is little doubt about the existence of this socio-economic gradient in health, but there remains a vivid debate about its source. In this paper, we...
Persistent link: https://www.econbiz.de/10012461384
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets that control adverse selection and assure adequate access and coverage. We model Part D enrollment and plan choice assuming a discrete dynamic decision...
Persistent link: https://www.econbiz.de/10012463257
Medicare Part D provides prescription drug coverage through Medicare approved plans offered by private insurance companies and HMOs. In this paper, we study the role of current prescription drug use and health risks, related expectations, and subjective factors in the demand for prescription...
Persistent link: https://www.econbiz.de/10012465012
Persistent link: https://www.econbiz.de/10012614341
Medicare Part D provides prescription drug coverage through Medicare approved plans offered by private insurance companies and HMOs. In this paper, we study the role of current prescription drug use and health risks, related expectations, and subjective factors in the demand for prescription...
Persistent link: https://www.econbiz.de/10012759665